Lyra Therapeutics Inc — Quarterly Cash Flow (NASDAQ:LYRA) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics

Quarterly Annual

Total assets 78.76 M66.35 M56.32 M52.57 M43.71 M Total liabilities 58.14 M54.75 M52.44 M50.95 M48.04 M Total equity 20.62 M11.59 M3.87 M1.62 M4.33 M Total liabilities & shareholders' equities 78.76 M66.35 M56.32 M52.57 M43.71 M Total debt ————— Net debt —————

ニュース

Lyra Therapeuticsが事業清算継続中に未払い賃料で債務不履行通知を受領

Lyra Therapeutics receives default notice for unpaid rent as wind-down continues

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)

Lyra Therapeutics halts development of lead CRS treatment

US Stocks Lower; Dow Tumbles Over 250 Points - Atara Biotherapeutics (NASDAQ:ATRA), Envirotech Vehicles (NASDAQ:EVTV)

BTIGがリラ・セラピューティクスの第3四半期決算後に「中立」評価を維持

BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates

Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates

Dentsply International (XRAY) Lags Q3 Earnings Estimates

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates